Volteface is accepting pitches for our website on this recent psilocybin study and what it means for psychedelic therapy. No particular deadline but the sooner the better – we’re always looking to commission pieces.
ABOUT THE COMPANY
Volteface is an independent research and advocacy organisation that seeks to reduce the harm drugs pose to individuals and society, through evidence-based policy reform. It cultivates fresh thinking and new ideas through our policy reports and online magazine.
WHAT TO INCLUDE IN SUBMISSION
More information: Interesting evidence on the use of psilocybin-assisted treatment: https://pubmed.ncbi.nlm.nih.
COMPENSATION
CONTACT
For more information, visit their visit.
Please email all questions and submissions to Katya Kowalski, Head of Operations at Volteface at katya@volteface.me.
Former Business Insider executive editor Rebecca Harrington has been hired by Dynamo to be its…
Bloomberg Television has hired Brenda Kerubo as a desk producer in London. She will be covering Europe's…
In a meeting at CNBC headquarters Thursday afternoon, incoming boss Mark Lazarus presented a bullish…
Ritika Gupta, the BBC's North American business correspondent, was interviewed by Global Woman magazine about…
Rest of World has hired Kinling Lo as a China reporter. Lo was previously a…
Bloomberg News saw strong unique visitor growth to its website in October, passing Fox Business…